Trinity Biotech (TRIB) Operating Income (QoQ) (2009 - 2024)
Trinity Biotech (TRIB) Operating Income (QoQ) (2009 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Trinity Biotech | 6.53 Mn | 1.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -350.08% |
| Sep 30, 2024 | 36.87% |
| Jun 30, 2024 | -33.25% |
| Mar 31, 2024 | 19.53% |
| Dec 31, 2023 | 16.02% |
| Sep 30, 2023 | 69.70% |
| Jun 30, 2023 | -278.97% |
| Mar 31, 2023 | 51.96% |
| Dec 31, 2022 | -0.32% |
| Sep 30, 2022 | -339.51% |
| Jun 30, 2022 | -52.14% |
| Mar 31, 2022 | -315.99% |
| Dec 31, 2021 | -79.66% |
| Sep 30, 2021 | 1,169.72% |
| Jun 30, 2021 | -92.92% |
| Mar 31, 2021 | -66.05% |
| Dec 31, 2020 | -0.21% |
| Sep 30, 2020 | 1,713.37% |
| Jun 30, 2020 | -70.41% |
| Mar 31, 2020 | 17.24% |